Acutus Medical, Inc.

AFIB

← Alla bolag

Transaktioner

271

Köp

211

Sälj

Nettoinsynsflöde

429.4 mn USD

Köpvärde minus säljvärde

Rapportanalys

Senast rapporterade siffror, automatiskt granskade

Läser senaste rapporten…

Aktiekurs och insynstransaktioner

Ingen prisdata ännu

Ingen prisserie har matchats mot detta bolag ännu.

Avkastning efter transaktion

Median-% efter transaktionsdatum

Kursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.

Signalkorrelation

Månatligt nettoinsynsflöde vs avkastning

–

Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.

Alla rapporterade transaktioner

271 rader

Datum	Person	Position	Typ	Volym	Pris	Värde
2024-03-01	Mukai Takeo	CFO	Sell	8 k	0,21	2 k USD
2024-03-01	Mukai Takeo	CFO	Sell	8 k	0,21	2 k USD
2024-02-06	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	8 k	0,17	1 k USD
2024-02-06	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	8 k	0,17	1 k USD
2024-02-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	6 k	0,19	1 k USD
2024-02-01	Mukai Takeo	CFO	Sell	3 k	0,19	548 USD
2024-02-01	Mukai Takeo	CFO	Sell	3 k	0,19	548 USD
2024-02-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	6 k	0,19	1 k USD
2024-01-07	Roman David	President & CEO	Sell	24 k	0,19	5 k USD
2024-01-07	Mathews Kevin	SVP, Commercial	Sell	6 k	0,19	1 k USD
2024-01-07	Mathews Kevin	SVP, Commercial	Sell	6 k	0,19	1 k USD
2024-01-07	Roman David	President & CEO	Sell	24 k	0,19	5 k USD
2023-09-01	Mukai Takeo	CFO	Sell	2 k	0,49	844 USD
2023-09-01	Mukai Takeo	CFO	Sell	2 k	0,49	844 USD
2023-08-05	Mathews Kevin	SVP, Commercial	Sell	134	0,69	92 USD
2023-08-05	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	433	0,69	299 USD
2023-08-05	Mathews Kevin	SVP, Commercial	Sell	134	0,69	92 USD
2023-08-05	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	433	0,69	299 USD
2023-08-02	Mukai Takeo	CFO	Sell	501	0,00	0 USD
2023-08-02	Mukai Takeo	CFO	Sell	501	0,00	0 USD
2023-08-01	Roman David	President & CEO	Sell	6 k	0,00	0 USD
2023-08-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Buy	20 k	0,00	0 USD
2023-08-01	Roman David	President & CEO	Sell	6 k	0,00	0 USD
2023-08-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Buy	20 k	0,00	0 USD
2023-06-15	Flynn James E	Director	Buy	8 k	0,00	0 USD
2023-06-15	Flynn James E	Director	Buy	8 k	0,00	0 USD
2023-06-15	Flynn James E	Director	Buy	8 k	0,00	0 USD
2023-06-15	Pellegrini Niamh Louise	Director	Buy	8 k	0,00	0 USD
2023-06-15	Garland Jason K	Director	Buy	8 k	0,00	0 USD
2023-06-15	ElBardissi Andrew	Director	Buy	8 k	0,00	0 USD
2023-06-15	Huennekens R Scott	Director	Buy	11 k	0,00	0 USD
2023-06-15	Bonita David P	Director	Buy	8 k	0,00	0 USD
2023-06-15	Sheridan John F	Director	Buy	8 k	0,00	0 USD
2023-06-15	Marzouk Shaden	Director	Buy	8 k	0,00	0 USD
2023-06-15	Bonita David P	Director	Buy	8 k	0,00	0 USD
2023-06-15	ElBardissi Andrew	Director	Buy	8 k	0,00	0 USD
2023-06-15	Garland Jason K	Director	Buy	8 k	0,00	0 USD
2023-06-15	Huennekens R Scott	Director	Buy	11 k	0,00	0 USD
2023-06-15	Marzouk Shaden	Director	Buy	8 k	0,00	0 USD
2023-06-15	Pellegrini Niamh Louise	Director	Buy	8 k	0,00	0 USD
2023-06-15	Sheridan John F	Director	Buy	8 k	0,00	0 USD
2023-06-01	Roman David	President & CEO	Sell	17 k	0,85	15 k USD
2023-06-01	Roman David	President & CEO	Sell	17 k	0,85	15 k USD
2023-04-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	855	0,75	645 USD
2023-04-01	Piscitello Charlie	SVP, Chief People Officer	Sell	855	0,75	645 USD
2023-04-01	Roman David	President & CEO	Sell	3 k	0,75	2 k USD
2023-04-01	Mathews Kevin	SVP, Commercial	Sell	321	0,75	242 USD
2023-04-01	Mathews Kevin	SVP, Commercial	Sell	321	0,75	242 USD
2023-04-01	Piscitello Charlie	SVP, Chief People Officer	Sell	855	0,75	645 USD
2023-04-01	Roman David	President & CEO	Sell	3 k	0,75	2 k USD
2023-04-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	855	0,75	645 USD
2023-03-01	Piscitello Charlie	SVP, Chief People Officer	Buy	43 k	0,00	0 USD
2023-03-01	Mukai Takeo	CFO	Buy	48 k	0,00	0 USD
2023-03-01	Roman David	President & CEO	Buy	135 k	0,00	0 USD
2023-03-01	Mathews Kevin	SVP, Commercial	Buy	43 k	0,00	0 USD
2023-03-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Buy	43 k	0,00	0 USD
2023-03-01	Mathews Kevin	SVP, Commercial	Buy	43 k	0,00	0 USD
2023-03-01	Mukai Takeo	CFO	Buy	48 k	0,00	0 USD
2023-03-01	Piscitello Charlie	SVP, Chief People Officer	Buy	43 k	0,00	0 USD
2023-03-01	Roman David	President & CEO	Buy	135 k	0,00	0 USD
2023-03-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Buy	43 k	0,00	0 USD
2023-02-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	7 k	1,87	12 k USD
2023-02-01	Mathews Kevin	SVP, Commercial	Sell	4 k	1,87	7 k USD
2023-02-01	Piscitello Charlie	SVP, Chief People Officer	Sell	7 k	1,87	12 k USD
2023-02-01	Roman David	President & CEO	Sell	10 k	1,87	19 k USD
2023-02-01	Mukai Takeo	CFO	Sell	3 k	1,87	5 k USD
2023-02-01	Mathews Kevin	SVP, Commercial	Sell	4 k	1,87	7 k USD
2023-02-01	Mukai Takeo	CFO	Sell	3 k	1,87	5 k USD
2023-02-01	Piscitello Charlie	SVP, Chief People Officer	Sell	7 k	1,87	12 k USD
2023-02-01	Roman David	President & CEO	Sell	10 k	1,87	19 k USD
2023-02-01	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	7 k	1,87	12 k USD
2022-10-01	Huennekens R Scott	Director	Buy	3 k	0,00	0 USD
2022-10-01	Huennekens R Scott	Director	Buy	3 k	0,00	0 USD
2022-09-01	Mukai Takeo	Interim CFO	Buy	20 k	0,00	0 USD
2022-09-01	Garland Jason K	Director	Buy	14 k	0,00	0 USD
2022-09-01	Garland Jason K	Director	Buy	14 k	0,00	0 USD
2022-09-01	Mukai Takeo	Interim CFO	Buy	20 k	0,00	0 USD
2022-08-05	Mathews Kevin	SVP, Global Sales	Sell	134	1,56	209 USD
2022-08-05	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	433	1,56	675 USD
2022-08-05	Piscitello Charlie	Chief People Officer	Sell	433	1,56	675 USD
2022-08-05	Mathews Kevin	SVP, Global Sales	Sell	134	1,56	209 USD
2022-08-05	Piscitello Charlie	Chief People Officer	Sell	433	1,56	675 USD
2022-08-05	Sohn Tom	SVP, Gen. Counsel & Secretary	Sell	433	1,56	675 USD
2022-08-01	Roman David	President & CEO	Buy	75 k	0,00	0 USD
2022-08-01	Roman David	President & CEO	Buy	75 k	0,00	0 USD
2022-06-16	Flynn James E	Director	Buy	8 k	0,00	0 USD
2022-06-16	Flynn James E	Director	Buy	8 k	0,00	0 USD
2022-06-16	Flynn James E	Director	Buy	8 k	0,00	0 USD
2022-06-16	Bonita David P	Director, 10% owner	Buy	8 k	0,00	0 USD
2022-06-16	ElBardissi Andrew	Director	Buy	8 k	0,00	0 USD
2022-06-16	Cramp Daniella	Director	Buy	8 k	0,00	0 USD
2022-06-16	Sheridan John F	Director	Buy	8 k	0,00	0 USD
2022-06-16	Pellegrini Niamh Louise	Director	Buy	8 k	0,00	0 USD
2022-06-16	Huennekens R Scott	Director	Buy	8 k	0,00	0 USD
2022-06-16	Hinrichs James F.	Director	Buy	8 k	0,00	0 USD
2022-06-16	Marzouk Shaden	Director	Buy	8 k	0,00	0 USD
2022-06-16	Bonita David P	Director, 10% owner	Buy	8 k	0,00	0 USD
2022-06-16	Cramp Daniella	Director	Buy	8 k	0,00	0 USD
2022-06-16	ElBardissi Andrew	Director	Buy	8 k	0,00	0 USD
2022-06-16	Hinrichs James F.	Director	Buy	8 k	0,00	0 USD
2022-06-16	Huennekens R Scott	Director	Buy	8 k	0,00	0 USD
2022-06-16	Marzouk Shaden	Director	Buy	8 k	0,00	0 USD
2022-06-16	Pellegrini Niamh Louise	Director	Buy	8 k	0,00	0 USD
2022-06-16	Sheridan John F	Director	Buy	8 k	0,00	0 USD
2022-06-03	Huennekens R Scott	Director	Sell	60 k	0,58	35 k USD
2022-06-03	Huennekens R Scott	Director	Sell	60 k	0,58	35 k USD
2022-06-01	Roman David	Chief Financial Officer	Buy	100 k	0,00	0 USD
2022-06-01	Roman David	Chief Financial Officer	Buy	100 k	0,00	0 USD
2022-04-01	Roman David	Chief Financial Officer	Sell	3 k	1,30	4 k USD
2022-04-01	McQuillan Steven	SVP, Clinical Affairs & QA	Sell	733	1,30	953 USD
2022-04-01	Burgess Vincent J	Chief Executive Officer	Sell	4 k	1,30	5 k USD
2022-04-01	Burgess Vincent J	Chief Executive Officer	Sell	4 k	1,30	5 k USD
2022-04-01	McQuillan Steven	SVP, Clinical Affairs & QA	Sell	733	1,30	953 USD
2022-04-01	Roman David	Chief Financial Officer	Sell	3 k	1,30	4 k USD
2022-02-01	Roman David	Chief Financial Officer	Buy	50 k	0,00	0 USD
2022-02-01	McQuillan Steven	SVP, Clinical Affairs & QA	Buy	32 k	0,00	0 USD
2022-02-01	McQuillan Steven	SVP, Clinical Affairs & QA	Buy	32 k	0,00	0 USD
2022-02-01	Roman David	Chief Financial Officer	Buy	50 k	0,00	0 USD
2021-11-15	Hinrichs James F.	Director	Buy	40 k	3,78	151 k USD
2021-11-15	Hinrichs James F.	Director	Buy	40 k	3,78	151 k USD
2021-08-10	Pellegrini Niamh Louise	Director	Buy	4 k	0,00	0 USD
2021-08-10	Pellegrini Niamh Louise	Director	Buy	4 k	0,00	0 USD
2021-08-05	Burgess Vincent J	Chief Executive Officer	Sell	2 k	15,52	30 k USD
2021-08-05	McQuillan Steven	SVP, Clinical Affairs & QA	Sell	305	15,52	5 k USD
2021-08-05	Burgess Vincent J	Chief Executive Officer	Sell	2 k	15,52	30 k USD
2021-08-05	McQuillan Steven	SVP, Clinical Affairs & QA	Sell	305	15,52	5 k USD
2021-07-19	Bonita David P	Director, 10% owner	Buy	714 k	14,00	10.0 mn USD
2021-07-19	Bonita David P	Director, 10% owner	Buy	357 k	14,00	5.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	714 k	14,00	10.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	357 k	14,00	5.0 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	Bonita David P	Director, 10% owner	Buy	714 k	14,00	10.0 mn USD
2021-07-19	Bonita David P	Director, 10% owner	Buy	357 k	14,00	5.0 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	391 k	14,00	5.5 mn USD
2021-07-19	Flynn James E	Director, 10% owner	Buy	681 k	14,00	9.5 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	714 k	14,00	10.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	357 k	14,00	5.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	714 k	14,00	10.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	357 k	14,00	5.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	714 k	14,00	10.0 mn USD
2021-07-19	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	357 k	14,00	5.0 mn USD
2021-06-17	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2021-06-17	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2021-06-17	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2021-06-17	Bonita David P	Director, 10% owner	Buy	2 k	0,00	0 USD
2021-06-17	ElBardissi Andrew	Director	Buy	2 k	0,00	0 USD
2021-06-17	Malik Shahzad	Director	Buy	2 k	0,00	0 USD
2021-06-17	Marzouk Shaden	Director	Buy	2 k	0,00	0 USD
2021-06-17	Hinrichs James F.	Director	Buy	2 k	0,00	0 USD
2021-06-17	Bonita David P	Director, 10% owner	Buy	2 k	0,00	0 USD
2021-06-17	ElBardissi Andrew	Director	Buy	2 k	0,00	0 USD
2021-06-17	Malik Shahzad	Director	Buy	2 k	0,00	0 USD
2021-06-17	Marzouk Shaden	Director	Buy	2 k	0,00	0 USD
2021-04-01	Burgess Vincent J	Chief Executive Officer	Buy	45 k	0,00	0 USD
2021-04-01	McQuillan Steven	SVP, Clinical Affairs & QA	Buy	10 k	0,00	0 USD
2021-04-01	Roman David	Chief Financial Officer	Buy	37 k	0,00	0 USD
2021-04-01	Burgess Vincent J	Chief Executive Officer	Buy	45 k	0,00	0 USD
2021-04-01	McQuillan Steven	SVP, Clinical Affairs & QA	Buy	10 k	0,00	0 USD
2021-04-01	Roman David	Chief Financial Officer	Buy	37 k	0,00	0 USD
2021-03-17	Sheridan John F	Director	Buy	3 k	0,00	0 USD
2021-03-17	Sheridan John F	Director	Buy	3 k	0,00	0 USD
2021-02-03	Cramp Daniella	Director	Buy	2 k	0,00	0 USD
2021-02-03	Cramp Daniella	Director	Buy	2 k	0,00	0 USD
2020-08-10	Malik Shahzad	Director	Buy	65 k	0,00	0 USD
2020-08-10	Malik Shahzad	Director	Buy	1.6 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	374 k	18,00	6.7 mn USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	42 k	18,00	747 k USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	3.8 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	1.3 mn	0,00	0 USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	374 k	18,00	6.7 mn USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	42 k	18,00	747 k USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	3.8 mn	0,00	0 USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	1.3 mn	0,00	0 USD
2020-08-10	Hinrichs James F.	Director	Buy	10 k	18,00	180 k USD
2020-08-10	Barnickel John	Chief Commercial Officer	Buy	7 k	18,00	131 k USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Barnickel John	Chief Commercial Officer	Buy	7 k	18,00	131 k USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	374 k	18,00	6.7 mn USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	42 k	18,00	747 k USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	3.8 mn	0,00	0 USD
2020-08-10	Bonita David P	Director, 10% owner	Buy	1.3 mn	0,00	0 USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	450 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.2 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	189 k	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	1.0 mn	–	–
2020-08-10	Flynn James E	Director, 10% owner	Buy	944 k	18,00	17.0 mn USD
2020-08-10	Flynn James E	Director, 10% owner	Buy	556 k	18,00	10.0 mn USD
2020-08-10	Hinrichs James F.	Director	Buy	10 k	18,00	180 k USD
2020-08-10	Malik Shahzad	Director	Buy	65 k	0,00	0 USD
2020-08-10	Malik Shahzad	Director	Buy	1.6 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	374 k	18,00	6.7 mn USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	42 k	18,00	747 k USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	3.8 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	1.3 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	374 k	18,00	6.7 mn USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	42 k	18,00	747 k USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	3.8 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	1.3 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	374 k	18,00	6.7 mn USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	42 k	18,00	747 k USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	3.8 mn	0,00	0 USD
2020-08-10	ORBIMED ADVISORS LLC	Director, 10% owner	Buy	1.3 mn	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Flynn James E	Director, 10% owner	Buy	2 k	0,00	0 USD
2020-08-05	Marzouk Shaden	Director	Buy	2 k	0,00	0 USD
2020-08-05	Malik Shahzad	Director	Buy	2 k	0,00	0 USD
2020-08-05	Hinrichs James F.	Director	Buy	1 k	0,00	0 USD
2020-08-05	Doherty Gary W.	Chief Financial Officer	Buy	5 k	0,00	0 USD
2020-08-05	Burgess Vincent J	Chief Executive Officer	Buy	22 k	0,00	0 USD
2020-08-05	Barnickel John	Chief Commercial Officer	Buy	7 k	0,00	0 USD
2020-08-05	ElBardissi Andrew	Director	Buy	2 k	0,00	0 USD
2020-08-05	Bonita David P	Director	Buy	2 k	0,00	0 USD
2020-08-05	Barnickel John	Chief Commercial Officer	Buy	7 k	0,00	0 USD
2020-08-05	Bonita David P	Director	Buy	2 k	0,00	0 USD
2020-08-05	Burgess Vincent J	Chief Executive Officer	Buy	22 k	0,00	0 USD
2020-08-05	Doherty Gary W.	Chief Financial Officer	Buy	5 k	0,00	0 USD
2020-08-05	ElBardissi Andrew	Director	Buy	2 k	0,00	0 USD
2020-08-05	Hinrichs James F.	Director	Buy	1 k	0,00	0 USD
2020-08-05	Malik Shahzad	Director	Buy	2 k	0,00	0 USD
2020-08-05	Marzouk Shaden	Director	Buy	2 k	0,00	0 USD